Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 209–216 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Akebia Therapeutics Inc. Vadadustat COVID-19 Phase 3 Ongoing Oral COVID-19
Akebia Therapeutics Inc. Vadadustat ARDS in subjects with COVID-19 and hypoxemia Phase 2 Data Released Oral COVID-19
Akebia Therapeutics Inc. Vadadustat ARDS in subjects with COVID-19 and hypoxemia Phase 2 Data Released Oral COVID-19
Akebia Therapeutics Inc. Vadadustat - (VALOR) Anemia due to chronic kidney disease (CKD) Phase 3 Withdrawn Oral Anti-Anemia
Alaunos Therapeutics Inc. Sleeping Beauty - Personalized TCR-T Program CD19+ leukemias and lymphomas Phase 2 Intravenous Oncology
Alaunos Therapeutics Inc. Sleeping beauty - TCR-T cell therapy Solid tumors Phase 2 Intravenous Oncology
Alaunos Therapeutics Inc. Ad-RTS-hIL-12 plus veledimex plus LIBTAYO (cemiplimab) Refractory glioblastoma multiforme (GBM) Phase 2 Intratumoral oral intravenous Oncology
Alcon Inc. ROCLATAN - (Mercury 3) Open Angle Glaucoma Phase 3 Data Released ophthalmic Opthalmic